stoxline Quote Chart Rank Option Currency Glossary
  
EDAP TMS S.A. (EDAP)
6.8  0.48 (7.59%)    03-01 16:00
Open: 6.5099
High: 6.95
Volume: 75,507
  
Pre. Close: 6.32
Low: 6.3219
Market Cap: 251(M)
Technical analysis
2024-03-01 4:52:01 PM
Short term     
Mid term     
Targets 6-month :  8.11 1-year :  9.48
Resists First :  6.94 Second :  8.11
Pivot price 6.1
Supports First :  6.05 Second :  5.5
MAs MA(5) :  6.13 MA(20) :  6.17
MA(100) :  5.84 MA(250) :  7.93
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  66 D(3) :  50
RSI RSI(14): 65.1
52-week High :  12.64 Low :  3.59
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ EDAP ] has closed Bollinger Bands are 25.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.96 - 6.99 6.99 - 7.01
Low: 6.26 - 6.29 6.29 - 6.31
Close: 6.75 - 6.8 6.8 - 6.84
Company Description

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Headline News

Tue, 02 Jan 2024
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer - Barron's

Tue, 12 Dec 2023
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU ... - Barron's

Thu, 16 Nov 2023
EDAP TMS S.A.'s (NASDAQ:EDAP) top owners are individual investors with 56% stake, while 29% is held by institutions - Yahoo Finance

Fri, 10 Nov 2023
EDAP TMS S.A. (NASDAQ:EDAP) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 02 Nov 2023
Vuzix Announces Partnership with EDAP TMS to Supply Smart Glasses for its Focal One® Robotic High Intensity ... - Yahoo Finance

Wed, 05 Apr 2023
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2022 Earnings Call Transcript - Insider Monkey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 37 (M)
Shares Float 29 (M)
Held by Insiders 0 (%)
Held by Institutions 43.3 (%)
Shares Short 110 (K)
Shares Short P.Month 79 (K)
Stock Financials
EPS -0.65
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.62
Profit Margin -37.7 %
Operating Margin -47.3 %
Return on Assets (ttm) -11.4 %
Return on Equity (ttm) -31.7 %
Qtrly Rev. Growth -4.1 %
Gross Profit (p.s.) 0
Sales Per Share 1.53
EBITDA (p.s.) -0.45
Qtrly Earnings Growth 0 %
Operating Cash Flow -17 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -10.47
PEG Ratio -3.6
Price to Book value 4.19
Price to Sales 4.44
Price to Cash Flow -14.86
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android